DrugCite
Search

DEBRIDAT

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Debridat Adverse Events Reported to the FDA Over Time

How are Debridat adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Debridat, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Debridat is flagged as the suspect drug causing the adverse event.

Most Common Debridat Adverse Events Reported to the FDA

What are the most common Debridat adverse events reported to the FDA?

Pyrexia
16 (3.47%)
Premature Baby
14 (3.04%)
Drug Exposure During Pregnancy
11 (2.39%)
Periventricular Leukomalacia
11 (2.39%)
Hypotension
9 (1.95%)
Inflammation
9 (1.95%)
Anaemia
8 (1.74%)
C-reactive Protein Increased
8 (1.74%)
Confusional State
7 (1.52%)
Foetal Growth Retardation
7 (1.52%)
Jaundice Neonatal
7 (1.52%)
Show More Show More
Pruritus
7 (1.52%)
Abdominal Pain
6 (1.3%)
Colitis
6 (1.3%)
Constipation
6 (1.3%)
Foetal Arrhythmia
6 (1.3%)
Haematocrit Decreased
6 (1.3%)
Hepatitis
6 (1.3%)
Hyponatraemia
6 (1.3%)
Lung Disorder
6 (1.3%)
Nervous System Disorder
6 (1.3%)
Vomiting
6 (1.3%)
Agranulocytosis
5 (1.08%)
Cytolytic Hepatitis
5 (1.08%)
Foetal Heart Rate Disorder
5 (1.08%)
Leukocytosis
5 (1.08%)
Neonatal Respiratory Distress Syndr...
5 (1.08%)
Pancreatitis Acute
5 (1.08%)
Protein Total Decreased
5 (1.08%)
Rash Maculo-papular
5 (1.08%)
Somnolence
5 (1.08%)
Staphylococcal Infection
5 (1.08%)
Thrombocytopenia
5 (1.08%)
Toxic Skin Eruption
5 (1.08%)
Transaminases Increased
5 (1.08%)
Urine Sodium Decreased
5 (1.08%)
Blood Bilirubin Increased
4 (.87%)
Dermatitis Bullous
4 (.87%)
Disturbance In Attention
4 (.87%)
Gamma-glutamyltransferase Increased
4 (.87%)
Lymphatic Disorder
4 (.87%)
Oedema Peripheral
4 (.87%)
Peripheral Ischaemia
4 (.87%)
Quadriparesis
4 (.87%)
Rectal Haemorrhage
4 (.87%)
Venous Insufficiency
4 (.87%)
Acute Generalised Exanthematous Pus...
3 (.65%)
Alanine Aminotransferase Increased
3 (.65%)
Anaemia Neonatal
3 (.65%)
Asthenia
3 (.65%)
Blood Alkaline Phosphatase Increase...
3 (.65%)
Condition Aggravated
3 (.65%)
Dermatitis
3 (.65%)
Ileitis
3 (.65%)
Jaundice
3 (.65%)
Leukopenia
3 (.65%)
Pregnancy With Contraceptive Device
3 (.65%)
Prothrombin Time Shortened
3 (.65%)
Rash Erythematous
3 (.65%)
Respiratory Distress
3 (.65%)
Skin Lesion
3 (.65%)
Stevens-johnson Syndrome
3 (.65%)
Anorexia
2 (.43%)
Aplasia
2 (.43%)
Ascites
2 (.43%)
Aspartate Aminotransferase Increase...
2 (.43%)
Breath Sounds
2 (.43%)
Burning Sensation
2 (.43%)
Cardiac Disorder
2 (.43%)
Cardiac Murmur
2 (.43%)
Chills
2 (.43%)
Coma
2 (.43%)
Dehydration
2 (.43%)
Diarrhoea
2 (.43%)
Enterobacter Infection
2 (.43%)
Enterocolitis Infectious
2 (.43%)
Epistaxis
2 (.43%)
Gastrointestinal Disorder
2 (.43%)
Gastrointestinal Toxicity
2 (.43%)
General Physical Condition Abnormal
2 (.43%)
Hepatocellular Injury
2 (.43%)
Hyperbilirubinaemia
2 (.43%)
International Normalised Ratio Incr...
2 (.43%)
Megacolon
2 (.43%)
Pneumonia Aspiration
2 (.43%)
Premature Labour
2 (.43%)
Quadriplegia
2 (.43%)
Rales
2 (.43%)
Rash Generalised
2 (.43%)
Renal Failure
2 (.43%)
Renal Failure Acute
2 (.43%)
Sedative Therapy
2 (.43%)
Shock
2 (.43%)
Sinus Bradycardia
2 (.43%)
Subileus
2 (.43%)
Toxic Epidermal Necrolysis
2 (.43%)
Volvulus
2 (.43%)
Weight Decreased
2 (.43%)
Abnormal Behaviour
1 (.22%)
Abortion Spontaneous
1 (.22%)
Accidental Overdose
1 (.22%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Debridat, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Debridat is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Debridat

What are the most common Debridat adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Debridat, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Debridat is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Debridat According to Those Reporting Adverse Events

Why are people taking Debridat, according to those reporting adverse events to the FDA?

Drug Use For Unknown Indication
54
Product Used For Unknown Indication
20
Abdominal Pain
13
Constipation
9
Gastrointestinal Motility Disorder
9
Gastrointestinal Disorder
8
Show More Show More
Sigmoiditis
6
Gastrointestinal Pain
5
Drug Exposure During Pregnancy
5
Ill-defined Disorder
4
Pain
4
Gastroenteritis
4
Nausea
3
Irritable Bowel Syndrome
3
Postoperative Care
2
Abdominal Discomfort
2
Prophylaxis
2
Intestinal Functional Disorder
2
Unevaluable Event
2
Colitis
2
Diverticulum
1
Abdominal Distension
1
Muscle Spasms
1
Gastric Disorder
1
Gastroduodenitis
1
Flatulence
1
Diarrhoea
1

Debridat Case Reports

What Debridat safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Debridat. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Debridat.